Company: CERO
Filing Date: 2025-01-21
Form Type: S-1/A
Source: 0001213900-25-004742
Chunk: 354

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-01-21
Form: S-1/A
Chunk 354
---
 other
rights and preferences as may be determined from time to time by the Company’s board of directors. As of December 31, 2023 and 2022,
there were no shares of preferred stock issued or outstanding.

Warrants —
At December 31, 2023 and 2022, there were Public Warrants and Private Placement Warrants outstanding. The Public Warrants
will become exercisable 30 days after the completion of a business combination. No warrants will be exercisable for cash unless the
Company has an effective and current registration statement covering the common stock issuable upon exercise of the warrants and a current
prospectus relating to such common stock.

Notwithstanding the foregoing,
if a registration statement covering the common stock issuable upon exercise of the Public Warrants is not effective within a specified
period following the consummation of a business combination, warrant holders may, until such time as there is an effective registration
statement and during any period when the Company shall have failed to maintain an effective registration statement, exercise warrants
on a cashless basis pursuant to the exemption provided by Section 3(a)(9) of the Securities Act, provided that such exemption is
available. If that exemption, or another exemption, is not available, holders will not be able to exercise their warrants on a cashless
basis. The Public Warrants will expire after the completion of a business combination or earlier upon redemption or liquidation.

Once the warrants become
exercisable, the Company may redeem the Public Warrants:

| ● | in                     
 whole and not in part; |

| ● | at a price of $0.01 per warrant; |

| ● | upon not less than 30 days’ prior written notice of redemption; |

| ● | if, and only if, the reported last sale price of Class A common stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations and recapitalizations), for any 20 trading days within a 30-trading-day period commencing at any time after the warrants become exercisable and ending on the third business day prior to the notice of redemption to warrant holders; and |

| ● | if, and only if, there is a current registration statement in effect with respect to the shares of Class A common stock underlying the warrants. |

If the Company calls the
Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do
so on a